Valuation: Isodiol International Inc.

Market Cap 3.91M 2.83M 2.42M 2.27M 2.07M 271M 3.95M 26.83M 10.43M 136M 10.62M 10.39M 450M P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 9.13M 6.6M 5.66M 5.29M 4.84M 632M 9.23M 62.64M 24.36M 317M 24.79M 24.26M 1.05B EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
1 week+9,900.00%
Current month+9,900.00%
1 month+9,900.00%
3 months+9,900.00%
6 months+9,900.00%
Current year+9,900.00%
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.29
10 years 0
Extreme 1.0E-6
16.9
Manager TitleAgeSince
Chief Executive Officer - 2017-05-23
Director of Finance/CFO - -
Corporate Officer/Principal - 2018-08-29
Director TitleAgeSince
Director/Board Member - 2017-05-23
Director/Board Member - 2018-08-29
Director/Board Member - 2018-11-20
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+9,900.00%+9,900.00%+9,900.00% 128
+0.34%-1.06%-14.12%-5.48% 13.09B
+0.04%-2.86%-35.89%-58.06% 4.85B
-0.72%-7.55%-7.99%-6.69% 4.59B
-3.71%-6.60%-2.46%-29.63% 4.09B
+1.05%-1.24%-23.25%+3.48% 3.51B
+0.04%-0.45%-11.34%-6.44% 3.34B
-1.00%-3.33%-13.18%+12.27% 3.33B
-2.19%-4.59%-19.98%-16.50% 2.43B
-0.65%-4.13%-30.80%-13.84% 1.67B
Average -0.68%-2.34%+974.10%+977.91% 4.09B
Weighted average by Cap. -0.48%-2.08%-16.36%-13.13%

Financials

2018 2019
Net sales 19.14M 13.84M 11.86M 11.09M 10.14M 1.32B 19.34M 131M 51.04M 665M 51.95M 50.82M 2.2B 22.25M 16.08M 13.78M 12.9M 11.79M 1.54B 22.48M 153M 59.33M 773M 60.39M 59.09M 2.56B
Net income -36.02M -26.04M -22.32M -20.88M -19.09M -2.49B -36.4M -247M -96.07M -1.25B -97.78M -95.66M -4.14B -126M -91.03M -78.01M -72.98M -66.72M -8.72B -127M -864M -336M -4.38B -342M -334M -14.48B
Net Debt -15.55M -11.24M -9.63M -9.01M -8.24M -1.08B -15.72M -107M -41.47M -541M -42.21M -41.3M -1.79B 5.22M 3.78M 3.24M 3.03M 2.77M 362M 5.28M 35.82M 13.93M 182M 14.18M 13.87M 601M
Logo Isodiol International Inc.
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. ISOLF Stock